methylenedioxyethamphetamine
Sign in to save'3,4-Methylenedioxy-N-ethylamphetamine (MDEA; also called MDE and colloquially, Eve') is an empathogenic psychoactive drug. MDEA is a substituted amphetamine and a substituted methylenedioxyphenethylamine. MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor.
Key facts
- Drug.legal_CA
- Schedule I
- Drug.drug_name
- MDEA
- Drug.image
- MDEA structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 235px
- Drug.image2
- MDEA molecule ball.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250px
- Drug.routes_of_administration
- Oral, insufflation, injection, rectal
- Drug.class
- Serotonin releasing agent; Entactogen
- Drug.ATC_prefix
- None
- Drug.legal_AU
- S9
- Drug.legal_BR
- F2
- Drug.legal_DE
- Anlage I
- Drug.legal_UK
- Class A
- Drug.legal_US
- Schedule I
- Drug.legal_UN
- Psychotropic Schedule I
- Drug.CAS_number
- 82801-81-8
via Wikipedia infobox
Research
186 papers- Hyperthermia associated with 3,4-methylenedioxyethamphetamine ('Eve').Anaesthesia · 1993
- Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in healthy volunteers.Biological psychiatry · 1992
- The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy").Pharmacology & toxicology · 1999
- Intentional overdose and death with 3,4-methylenedioxyethamphetamine (MDEA; "Eve"): case report.The American journal of forensic medicine and pathology · 1998
- Serotonin syndrome unmasking thyrotoxicosis.BMJ case reports · 2019
via PubMed
Article
15 sectionsContents
- Uses
- Medical
- Recreational
- Adverse effects
- Overdose
- Interactions
- Chemistry
- Synthesis
- History
- Society and culture
- Legal status
- United States
- See also
- References
- External links
'3,4-Methylenedioxy-N-ethylamphetamine (MDEA; also called MDE and colloquially, Eve') is an empathogenic psychoactive drug. MDEA is a substituted amphetamine and a substituted methylenedioxyphenethylamine. MDEA acts as a serotonin, norepinephrine, and dopamine releasing agent and reuptake inhibitor.
Possession of MDEA is illegal in most countries. Some limited exceptions exist for scientific and medical research.
Connections
Categories
Chemical pages without DrugBank identifierDesigner drugsDrugs not assigned an ATC codeECHA InfoCard ID from WikidataEntactogensEuphoriantsInfobox drug articles with non-default infobox titleMethylenedioxyamphetaminesPartial monoamine releasing agentsPiHKALSerotonin-norepinephrine-dopamine releasing agentsSerotonin receptor agonists